• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT SRL ALINIQ AMS; CALCULATOR/DATA PROCESSING MODULE, FOR CLINICAL USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT SRL ALINIQ AMS; CALCULATOR/DATA PROCESSING MODULE, FOR CLINICAL USE Back to Search Results
Model Number 03R89-47
Device Problem Computer Software Problem (1112)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/02/2020
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.No specific patient information was provided.
 
Event Description
The customer reported the incorrect assay was ran while using the aliniq ams software.Sample id: (b)(6) generated a folate result of 101.71 from an analyzer that did not have a folate reagent installed.The result was actually ferritin and not the ordered folate.Review of the incident found the mapping of the aliniq ams had a configuration error in which the folate test was configured with the ferritin assay code.Additionally, a similar error was identified for the urine total protein which had the assay code for urine phosphatase.A look back was performed, and 170 folate patient results were impacted and 31 urine total protein results were impacted.To date, there has been no report of adverse impact to patient management.
 
Manufacturer Narrative
H6 conclusion code: 4316: issue caused by configuration error by a company representative.The investigation performed by the aliniq ams technical group indicated that the unexpected behavior of the middleware was due to an incorrect configuration of the test-channel association in the analyzer section performed during the system installation and configuration phase.Inconsistency of test results between the middleware and the abbott instrument (alinity ci) was due to a misconfiguration of the folates assay code that was configured using the ferritin assay code instead.The aliniq ams mapping had the same incorrect test-channel association for urine miction total protein (umpt) which had the assay code for urine miction phosphatase (ump).The issue was resolved through a configuration change within the aliniq ams middleware settings at the customer site: channel codes of the folates (fol) and urine miction total protein (umpt) tests were properly associated in the analyzer section on the middleware.Review of complaint activity and trending data did not identify any issues.The aliniq ams configurator user manual 2.11 provides labelling information on configuration the test channel codes.Based on the available information and this investigation, no systemic issue or deficiency of the aliniq ams, version 2.11 was identified.
 
Event Description
The customer reported the incorrect assay was ran while using the aliniq ams software.Sample id (b)(6) generated a folate result of 101.71 from an analyzer that did not have a folate reagent installed.The result was actually ferritin and not the ordered folate.Review of the incident found the mapping of the aliniq ams had a configuration error in which the folate test was configured with the ferritin assay code.Additionally, a similar error was identified for the urine total protein which had the assay code for urine phosphatase.A look back was performed and 170 folate patient results were impacted and 31 urine total protein results were impacted.To date there has been no report of adverse impact to patient management.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINIQ AMS
Type of Device
CALCULATOR/DATA PROCESSING MODULE, FOR CLINICAL USE
Manufacturer (Section D)
ABBOTT SRL
via giorgio ribotta 9
rome 00144
IT  00144
MDR Report Key11076190
MDR Text Key223795122
Report Number3004032053-2020-00006
Device Sequence Number1
Product Code JQP
UDI-Device Identifier00380740189907
UDI-Public00380740189907
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 01/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number03R89-47
Device Catalogue Number03R89-47
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 12/02/2020
Initial Date FDA Received12/28/2020
Supplement Dates Manufacturer Received12/28/2020
Supplement Dates FDA Received01/08/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-